Molecular aging is the main driver of Parkinson’s Disease

preprint OA: closed
📄 Open PDF Full text JSON View at publisher
Full text 2,809 characters · extracted from oa-doi-fallback · click to expand
Abstract Aging as well as the presence of α-synuclein (α-syn) oligomers in the brain are indisputably linked to Parkinson’s disease (PD). A central concept of geroscience is that the biological processes of aging drive the onset of aging-associated diseases. The extent to which the biological processes of aging directly contribute to PD and the inter-relationship with α-syn oligomers for the onset of PD symptoms remains unclear. Using an inducible α-syn oligomer mouse model of PD, we demonstrate that the induction of PD associated α-syn oligomers for the same timespan caused PD associated symptoms only in aged, but not in young mice. Biochemical studies revealed that α-syn oligomer formation precedes motor decline in these aged mice, and age together with α-syn expression determine the motor phenotype. Single-nucleus RNA sequencing (snRNA-seq) identified a PD disease signature that was particularly linked to basal ganglia neurons (BGNs) and was in part shared with an aging transcriptional signature. PD symptoms, as well as the PD Signature, were significantly altered by a short-term pharmacological attenuation of the activity of the small RhoGTPase CDC42 in already aged animals with PD symptoms. Attenuation of activity of CDC42 is known to target the general biological processes of aging. Interestingly, the intervention did not affect the amount of α-syn oligomers in the animals, while still improving phenotypes. Together, the data demonstrates that the biological processes of aging are a major causative driver for the onset of PD in the α-syn model of PD. Competing Interest Statement K. M. Danzer and H. Geiger are listed as inventors on a patent application related to this technology. The authors declare no further competing interests. Abbreviations - α-syn - α-synuclein - Adcy - adenylyl cyclase - ASC - astrocytes - AUC - area under the curve - BGNs - basal ganglia neurons - CASIN - CDC42 activity specific inhibitor - CDC42 - cell division control protein 42 homolog - CHOR - choroid plexus - CPS - counts per second - DaN - dopaminergic neurons - DEGs - differentially expressed genes - GEMs - gel beads-in-emulsion - Grm5 - glutamate metabotropic receptor 5 - M - month - MAR - missing at random - MassSpec - Mass Spectrometry - MGL - microglia - MNAR - missing not at random - nUMI - number of unique molecular identifiers - OLG - oligodendrocytes - OPC - oligodendrocyte progenitor cells - PCA - protein complementation assay - PD - Parkinson’s Disease - PDE - phosphodiesterase - PID - partial information decomposition - PKA - protein kinase A - SEC - Size-Exclusion Chromatography - snRNA-seq - single-nuclei RNA-sequencing - UMAP - Uniform Manifold Approximation and Projection algorithm - UPS - ubiquitin-proteasome system - Vo - void volume - VSC - vascular cells

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00